Juliet Campbell

Adult (those aged 19 and above) apprenticeship starts in the Broxtowe parliamentary constituency and Nottinghamshire local authority from the 2018/19 academic year onwards are shown in the table below.

Note:

(1) Figures are rounded to the nearest 10 and cover the finalised full academic year.

(2) Total starts are the count of apprenticeships started at any point during the stated academic period. Learners starting more than one apprenticeship will appear more than once.

(3) Geography is based on the learner home postcode.

(4) Broxtowe is based upon the 2024 parliamentary constituency boundary.

(5) Age is based on that at the start of the programme.

The department also publishes apprenticeship starts by age group as a proportion of the population, with breakdowns available by local authority. The latest figures for Nottinghamshire covering the 2018/19 to 2023/24 academic years are shown here:
https://explore-education-statistics.service.gov.uk/data-tables/permalink/09bc3f03-2391-4b73-6d25-08dd48e2728c.

In the ‘School accountability reform – school profiles improvement and intervention’ consultation, the department defined stuck school as a school that was graded requires improvement, or equivalent, at its most recent Ofsted inspection and was also graded below good at its previous inspection.

For this purpose, we have considered a sub-judgement of requires improvement for leadership and management and/or quality of education for a school inspected in the 2024/25 academic year as equivalent to a previous single headline grade of requires improvement.

Based on the latest published Ofsted inspection data, at the end of December 2024 there were:

• 0 stuck schools in Broxtowe.
• 12 stuck schools in Nottinghamshire.
• 664 stuck schools in England.

The Government is committed to enabling local highway authorities to maintain and renew their local highway networks. Decisions on which materials to use to repair their roads are matters for local highway authorities, but the Government encourages them to trial innovative processes and materials. The Department is currently supporting a £30 million “Live Labs” research programme, part of which allows innovative and environmentally friendly road-mending materials of this sort to be trialled and evaluated. The lessons learned will be shared with other local highway authorities.

A number of UK research institutions, including Swansea and Cambridge universities, are working on advanced materials, including self-healing asphalt, for filling potholes and resurfacing roads. Self-healing asphalt could potentially help prevent cracks from turning into potholes, but the technology is at an early stage and has not been tested at scale.

We are aware that there is a delay in NHS England allocating some foundation year one doctors their programme details and work schedules. We have asked NHS England to urgently tackle this issue. We know there is more to do and NHS England is working to ensure that all posts are confirmed as soon as possible, while keeping applicants informed throughout the process, including through webinars.

NHS England is due to review the foundation programme allocation process to make sure it works well for applicants. The review is scheduled for after the 2025/26 allocations and is aiming to commence in 2026. NHS England will advise stakeholders on how they can input in due course.

Integrated care boards (ICBs) are responsible for commissioning services for their local population, including for multiple sclerosis (MS). The Government expects ICBs to assess the demand for service provision when designing their local services.

There are initiatives to support better care for patients with neurological conditions like MS, across England. These include the Getting It Right First Time Programme for Neurology, which aims to improve MS care by supporting the National Health Service to address variations in care and by promoting best practice.

The Progressive Neurological Conditions Toolkit, published by NHS England’s RightCare Programme, supports healthcare systems in improving the care of individuals living with progressive neurological conditions, including MS. It aims to enhance local services and reduce hospital admissions by focusing on preventative care and by optimising the delivery of services.

NHS England’s Neurology Transformation Programme (NTP) is a multi-year programme to develop a new model of integrated care for neurology services. The NTP has collaborated with clinicians and patient groups to create specific pathways for MS, aiming to improve the quality and coordination of care.

NHS England is also updating its Specialised Neurology service specification, which includes MS. Service specifications define the standards of care expected from organisations funded by NHS England to provide specialised care.

Our 10-Year Health Plan will set out a bold agenda to deliver on the three big shifts needed, to move healthcare from the hospital to the community, from analogue to digital, and from treatment to prevention. We also plan to publish our refreshed Long Term Workforce Plan to deliver a transformed health service over the next decade and to treat patients wherever they live in England, including those with MS, on time again.

The Government is committed to protecting those most vulnerable to COVID-19 through vaccination, as guided by the independent Joint Committee on Vaccination and Immunisation (JCVI).

The JCVI stated in its advice for the autumn 2024 COVID-19 vaccination programme that there remains considerable uncertainty regarding the impact of additional vaccine doses, beyond the primary vaccination, on the risk, progression, and outcome of post-COVID syndromes. The JCVI advised that better data is needed on the impact of additional vaccine doses on the occurrence and severity of post-COVID syndromes in the current era of omicron sub-variants of the COVID-19 virus, and high population immunity. This advice is available at the following link:

https://www.gov.uk/government/publications/covid-19-autumn-2024-vaccination-programme-jcvi-advice-8-april-2024/jcvi-statement-on-the-covid-19-vaccination-programme-for-autumn-2024-8-april-2024

On 13 November 2024, the JCVI published advice on the COVID-19 vaccination programmes in spring 2025, autumn 2025, and spring 2026. This advice is available at the following link:

https://www.gov.uk/government/publications/covid-19-vaccination-in-2025-and-spring-2026-jcvi-advice/jcvi-statement-on-covid-19-vaccination-in-2025-and-spring-2026

The Government has accepted the JCVI’s advice on eligibility for the spring 2025 COVID-19 vaccination programme, to include those aged 75 years old and above, those aged six months old or above with immunosuppression, and those living in care homes for older adults. The Government response is available at the following link:

https://www.gov.uk/government/news/advice-accepted-on-spring-2025-covid-19-vaccination-programme

The Government is considering the advice for autumn 2025 and spring 2026 carefully, and will respond in due course.

NHS England has invested £314 million since the start of the pandemic to provide care and support for people with long COVID. This includes establishing specialist clinics throughout England to assess adults, children, and young people who are experiencing long-term effects of COVID-19 infection. A further £86.7 million of funding was included in integrated care board core allocations for 2024/25, and specific regional funding was also allocated for assurance and system support.

These services offer physical, cognitive, and psychological assessment, and, where appropriate, refer patients onto existing services for treatment and rehabilitation. Further information can be found via the National Health Service website, at the following link:

https://www.england.nhs.uk/coronavirus/post-covid-syndrome-long-covid/

Between 2019/20 and 2023/24, through the National Institute for Health and Care Research and the Medical Research Council, we have invested over £57 million on research into long COVID, with almost £40 million of this through two specific research calls on long COVID. The funded projects aim to improve our understanding of the diagnosis and underlying mechanisms of the disease and the effectiveness of both pharmacological and non-pharmacological therapies and interventions, as well as to evaluate the effectiveness of clinical care.

On 22 May 2025, the Government announced that it was formally accepting the 2025/26 headline pay recommendations for National Health Service staff in England from the NHS Pay Review Body, the Review Body on Doctors and Dentists Remuneration, and the Senior Salaries Review Body. These awards will be backdated to 1 April 2025, and staff can expect to receive their awards from August.

All Agenda for Change (AfC) pay points in England will be uplifted by 3.6% for 2025/26. We have also accepted the recommendation to provide the NHS Staff Council with a funded mandate to deliver changes to the AfC pay structure. We will work with the NHS Staff Council so that we can implement the changes by 1 April 2026.

We are committed to training the staff we need to ensure that patients are cared for by the right professional, when and where they need it.

We will ensure that the number of medical specialty training places meets the demands of the National Health Service in the future. NHS England will work with stakeholders to ensure that any growth is sustainable and focused in the service areas where the need is greatest.

To reform the NHS and make it fit for the future, we have launched a 10-Year Health Plan as part of the Government’s five long-term missions. Ensuring we have the right people, in the right places, with the right skills will be central to this vision. We will publish a refreshed workforce plan to deliver the transformed health service we will build over the next decade, and treat patients on time again.

The commissioning responsibility for interstitial lung disease (ILD) services has been delegated to the integrated care boards (ICBs), to facilitate joined up care and the configuration of services that will meet local needs.

Early and accurate diagnosis is a priority for NHS England, and the work to improve this area of clinical care is underway, which should have an impact on reducing delayed diagnosis of ILD. The Specialised Respiratory Clinical Reference Group is looking to update the national service specification during 2025/26, and this refresh will include an Equality Health Impact Assessment to support local implementation. The specification will cover diagnosis, management, and ongoing care for patients with ILD.

NHS England also funds the cost of anti-fibrotic treatments for ILD. Access to these treatments has recently been expanded to patients with non-idiopathic pulmonary fibrosis following the publication of the National Institute for Health and Care Excellence’s technology appraisal, Nintedanib for treating progressive fibrosing interstitial lung diseases, in November 2021.

Furthermore, pulmonary rehabilitation plays an important role in the management of patients with ILD and should be made available to all patients who would benefit from this intervention, not just those with chronic obstructive pulmonary disease (COPD). To better understand the uptake of this intervention, NHS England is aiming to modify the current National Asthma and COPD Audit Programmes so that conditions other than COPD are included, and service availability can be tracked.

Patients, including those in Nottinghamshire, have the right to choose their provider when referred to consultant-led treatment, or to a mental health professional, for their first appointment as an outpatient. Further information on the choices available for patients can be found on the NHS Choice framework, which is available at the following link:

https://www.gov.uk/government/publications/the-nhs-choice-framework

Information on autism assessments is not held centrally in the format requested, but may be held by individual providers or integrated care boards (ICBs). Some relevant information is available on autism assessment waiting times for the NHS Nottingham and Nottinghamshire ICB and the Midlands commissioning region.

In the NHS Nottingham and Nottinghamshire ICB, the Autism Waiting Time Statistics published by NHS England show that there were a total of 6,120 patients of all-ages with an open suspected autism referral in December 2024, the latest available data. The median waiting time of all patients in this ICB with an open suspected autism referral, where their first care contact was in the quarter, was 244 days in December 2024.

In the Midlands commissioning region, the Autism Waiting Time Statistics show that there were a total of 58,445 patients of all-ages with an open suspected autism referral in December 2024. The median waiting time of all patients in the Midlands commissioning region with an open suspected autism referral, where their first care contact was in the quarter, was 352 days in December 2024.

Caution should be used when interpreting these statistics since they are experimental rather than official statistics.

Schools decide whether a pupil has additional needs that warrant them being on the school's Special Educational Needs and Disabilities register. Some relevant information on waiting times for Education, Health and Care Plans (EHCPs) for children with Special Educational Needs and Disabilities is available from the GOV.UK website, from Education, health and care plans: England 2024, with the latest data available being from 2023. In Nottingham,

TARGET DATE 05/03/2025

67.1% of EHCPs, including exceptions, were issued within 20 weeks and in the East Midlands 40.4% of EHCPs, including exceptions, were issued within 20 weeks.

The Department has no plans to discuss Androfeme with the National Institute for Health and Care Excellence (NICE) and has made no assessment of the potential merits of prescribing Androfeme. Androfeme does not have a marketing authorisation for use in the United Kingdom.

Newly licensed medicines are appraised by the NICE, which is the independent body responsible for developing evidence-based guidance for the National Health Service on new medicines that represent a clinically and cost-effective use of resources. If Androfeme is granted a marketing authorisation in the future for this indication, the NICE will consider producing guidance under the appropriate programme, such as its technology appraisal programme.

The Department has no plans to discuss Androfeme with the National Institute for Health and Care Excellence (NICE) and has made no assessment of the potential merits of prescribing Androfeme. Androfeme does not have a marketing authorisation for use in the United Kingdom.

Newly licensed medicines are appraised by the NICE, which is the independent body responsible for developing evidence-based guidance for the National Health Service on new medicines that represent a clinically and cost-effective use of resources. If Androfeme is granted a marketing authorisation in the future for this indication, the NICE will consider producing guidance under the appropriate programme, such as its technology appraisal programme.

Data on waiting times for dyslexia assessments is not held centrally.

Assessments for dyslexia in children are currently provided by an educational psychologist or an appropriately qualified specialist dyslexia teacher. If a parent thinks their child may be dyslexic, as a first step they should speak to their child’s teacher or their school's special educational needs co-ordinator about their concerns. They may be able to offer additional support to help the child if necessary.

Adults who wish to be assessed for dyslexia are advised to contact a local or national dyslexia association for advice. Further information on dyslexia assessments is available at the following link:

https://www.nhs.uk/conditions/dyslexia/diagnosis/

The Government is committed to patients having the right to choose their provider when referred to consultant-led treatment, or to a mental health professional, for their first appointment as an outpatient. This is a legal right for patients set out in legislation.

There is, at present, no single, established dataset that can be used to monitor waiting times for assessment and diagnosis for attention deficit hyperactivity disorder (ADHD) nationally or for individual organisations or geographies in England.  Although the data requested is not held centrally, relevant information may be held locally by individual National Health Service trusts or commissioners.

We are supportive of a taskforce that NHS England has established to look at ADHD service provision and its impact on patient experience. The taskforce is bringing together expertise from across a broad range of sectors, including the NHS, education and justice, to better understand the challenges affecting people with ADHD including timely access to services and support.

In conjunction with the taskforce, NHS England has carried out detailed work to develop a data improvement plan, understand the provider and commissioning landscape and capture examples from integrated care boards who are trialling innovative ways of delivering ADHD services.

As of 4 February 2025, there are seven National Health Service practices in the Broxtowe constituency. In Nottingham, there are 110 NHS practices. In the East Midlands, there are 466 NHS practices.

This data is sourced from the Find a Dentist website and is matched to constituencies based on the postcode data shown on the website, which is available at the following link:

https://www.nhs.uk/service-search/find-a-dentist

Comparable data is not available for any of the earlier years.

The Dental Statistics - England 2023/24, published by the NHS Business Services Authority on 22 August 2024, is available from the following link:

https://www.nhsbsa.nhs.uk/statistical-collections/dental-england/dental-statistics-england-202324

In the NHS Nottingham and Nottinghamshire Integrated Care Board, which includes Nottinghamshire, 42% of adults were seen by a National Health Service dentist in the previous 24 months to June 2024, compared to 40% in England. In addition, 60% of children were seen by an NHS dentist in the previous 12 months to June 2024, compared to 56% in England.

Within the Midlands region, which includes the East Midlands, 42% of adults were seen by an NHS dentist in the previous 24 months to June 2024, compared to 40% in England. Additionally, 56% of children were seen by an NHS dentist in the previous 12 months to June 2024, compared to 56% in England.

The Government plans to tackle the challenges for patients trying to access NHS dental care with a rescue plan to provide 700,000 more urgent dental appointments and recruit new dentists to areas that need them most.

We know there are challenges with accessing National Health Service dentistry across the country. 28% of adults in England, or 13 million people, are estimated to have an unmet need for NHS dentistry.

The following table shows the number of dentists per 100,000 people in the Nottingham and Nottinghamshire Integrated Care Board (ICB), from 2019/20 to 2023/24:

Source: data is published by the NHS Business Services Authority and is available at the following link: https://www.nhsbsa.nhs.uk/statistical-collections/dental-england/dental-statistics-england-202324

We know there are challenges with accessing National Health Service dentistry across the country. 28% of adults in England, or 13 million people, are estimated to have an unmet need for NHS dentistry.

The following table shows the number of dentists per 100,000 people in the Nottingham and Nottinghamshire Integrated Care Board (ICB), from 2019/20 to 2023/24:

Source: data is published by the NHS Business Services Authority and is available at the following link: https://www.nhsbsa.nhs.uk/statistical-collections/dental-england/dental-statistics-england-202324

As of 4 February 2025, there were seven National Health Service dentist practices in the Broxtowe constituency, with three showing as ‘accepting new child patients when availability allows’ and three showing as ‘accepting new adult patients when availability allows’. In the Nottingham and Nottinghamshire Integrated Care Board, there were 110 NHS dentist practices, with 46 showing as ‘accepting new child patients when availability allows’ and 34 showing as ‘accepting new adult patients when availability allows’. In the East Midlands, there were 466 NHS dentist practices, 185 of these are showing as ‘accepting new child patients when availability allows’ and 124 showing as ‘accepting new adult patients when availability allows’. This data is sourced from the Find a Dentist website and is matched to constituencies based on the postcode data shown on the website, which is available at the following link:

https://www.nhs.uk/service-search/find-a-dentist/